Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity
about
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies.Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry diseaseScreening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy.Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.Renal function predicts long-term outcome on enzyme replacement therapy in patients with Fabry disease.Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease.Fabry disease and its cardiac involvement.Anderson-Fabry disease in heart failure
P2860
Q34460145-63DF4AD3-ADB3-4F35-8DC7-56F88EB1924FQ36309032-905430F1-A895-43F9-8325-78A2524898C5Q36758364-9D8E8023-5FE6-4FB4-97F4-E3E0B5DDA9E7Q36934478-287B946A-3897-4E92-A869-9DD4F85FFAA7Q38230252-08CC557A-509A-46BD-9058-7F9E3AEC3884Q39344648-37CAB696-D844-4E48-863A-976903FD6E15Q39390119-FA7CEFED-D2B7-40F2-A829-4CAB32DA4275Q39715709-A6020D3B-F58C-4A59-844F-D2F784D371B4Q55209521-9B408B08-823A-4C29-BE83-95AA577F2A54Q56807662-2354E8E9-17D0-42A3-8B5E-89260F1E9227
P2860
Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cardiovascular manifestations ...... alpha-galactosidase A activity
@ast
Cardiovascular manifestations ...... alpha-galactosidase A activity
@en
Cardiovascular manifestations ...... alpha-galactosidase A activity
@nl
type
label
Cardiovascular manifestations ...... alpha-galactosidase A activity
@ast
Cardiovascular manifestations ...... alpha-galactosidase A activity
@en
Cardiovascular manifestations ...... alpha-galactosidase A activity
@nl
prefLabel
Cardiovascular manifestations ...... alpha-galactosidase A activity
@ast
Cardiovascular manifestations ...... alpha-galactosidase A activity
@en
Cardiovascular manifestations ...... alpha-galactosidase A activity
@nl
P2093
P2860
P356
P1476
Cardiovascular manifestations ...... alpha-galactosidase A activity
@en
P2093
Justina C Wu
Katherine Sims
Maryam Banikazemi
Rekha Abichandani
Scott D Solomon
Seymour Packman
William R Wilcox
P2860
P304
P356
10.1093/EURHEARTJ/EHP588
P577
2010-01-07T00:00:00Z